Prospect Capital Announces Annual Meeting Update
Rhea-AI Summary
Prospect Capital (NASDAQ: PSEC) held its adjourned annual meeting of stockholders on January 8, 2026. The proposals considered mirror those in the definitive proxy filed September 18, 2025.
As of September 17, 2025, outstanding shares included 465,087,009 common shares and multiple preferred series (examples: 26,232,644 Series A1; 23,857,330 Series A3; 6,961,866 Floating Rate Series A4; 2,143,366 Series A5; plus others). Common and preferred shares each carry one vote per share on matters for their class.
To allow additional solicitation of votes, the Annual Meeting is adjourned to January 15, 2026 at 4:00 p.m. ET, to be held online at www.virtualshareholdermeeting.com/PSEC2025.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
PSEC was flat on the day, while key asset-management peers like GSBD, MFIC, OCSL, CSWC, and PX each gained around 3–4%. The lack of price move in PSEC versus broad peer strength suggests today’s annual-meeting update was viewed as company-specific and operational rather than a sector catalyst.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 16 | Annual meeting update | Neutral | -2.0% | Adjourned 2025 annual meeting to Jan 8, 2026 for additional proxy votes. |
| Nov 06 | Quarterly earnings | Positive | +0.4% | Reported NII, net income rebound, NAV and distributions for Sept 30, 2025 quarter. |
| Nov 05 | Earnings call schedule | Neutral | -1.6% | Announced timing and access details for Q1 earnings release and conference call. |
| Oct 28 | Debt offering | Neutral | +0.4% | Priced about $167M of 5.5% Series A senior unsecured notes due 2030. |
| Sep 08 | New investment | Neutral | -0.3% | Completed roughly $18M investment in The Ridge addiction treatment facility. |
Recent PSEC news — including earnings, debt offerings, and prior meeting adjournments — has generally produced only modest single-day price moves, with limited directional follow-through.
Over the past few months, PSEC updates have focused on capital structure, portfolio activity, and governance processes. The December 2025 annual meeting was previously adjourned to Jan 8, 2026 to gather more votes, mirroring today’s further adjournment. In November 2025, PSEC reported quarterly NII of $79.35M, NII per share of $0.17, and NAV of $6.45, while also issuing $167M of 5.5% notes due 2030. An $18M investment in The Ridge highlighted ongoing deployment into middle‑market credit. Viewed together, today’s notice continues an administrative governance theme rather than introducing new financial metrics.
Market Pulse Summary
This announcement updates shareholders that PSEC’s adjourned annual meeting has been further postponed to January 15, 2026 to allow more time to solicit votes on proposals described in the September 18, 2025 proxy statement. It reiterates the detailed common and preferred share counts as of September 17, 2025 and confirms equal voting rights within each class. Investors may focus on how final vote outcomes could influence governance or capital structure, while also tracking upcoming financial disclosures for a fuller picture.
Key Terms
proxy statement regulatory
cumulative perpetual preferred stock financial
floating rate financial
AI-generated analysis. Not financial advice.
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced that it held its adjourned annual meeting of stockholders (the “Annual Meeting”) on January 8, 2026. The proposals that were considered at the Annual Meeting are described in detail in the Company’s definitive proxy statement for the Annual Meeting as filed with the Securities and Exchange Commission on September 18, 2025 (the “Proxy”). As of September 17, 2025, there were 465,087,009 shares of the Company's common stock outstanding, 26,232,644 shares of the Company’s
About Prospect Capital Corporation
Prospect is a business development company that primarily lends to and invests in middle market privately-held companies. Prospect’s investment objective is to generate both current income and long-term capital appreciation.
Prospect has elected to be treated as a business development company under the Investment Company Act of 1940. Prospect has elected to be treated as a regulated investment company under the Internal Revenue Code of 1986.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, whose safe harbor for forward-looking statements does not apply to business development companies. Any such statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that we may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements. Such statements speak only as of the time when made, and we undertake no obligation to update any such statement now or in the future.
For additional information, contact:
Grier Eliasek, President and Chief Operating Officer
grier@prospectcap.com
Telephone (212) 448-0702